Artimplant presents the three months interim report 2008 at the AGM on May 6, 05:00 PM (GMT+1) Västra Frölunda, Sweden, April 30, 2008 CEO Hans Rosén and CFO Lars-Johan Cederbrant present the three months interim report 2008 at the AGM on May 6, 05:00 PM (GMT+1). The presentation will be in Swedish. After the AGM the presentation will be published at the website of the Company. No conference call will be held regarding this interim report. Please note that Artimplant's three months interim report 2008 will be distributed with a press release on May 6, 2008, approximately 04:00 PM Central European Time (GMT+1). For further information, please contact: Hans Rosén, CEO, phone +46 (0)31-746 56 00, +46 (0)708 58 34 70, hans.rosen@artimplant.com Lars-Johan Cederbrant, CFO, phone +46 (0)31-746 56 54, +46 (0)703 01 68 54, lars-johan.cederbrant@artimplant.com Further information at www.artimplant.com where one also can subscribe to future press releases; www.artimplant.com/investors-media/subscribe-to-press-releases.html About Artimplant Artimplant is a biomaterials company focused on solutions to problems in orthopedic and oral surgery. We restore health through the development, production, and marketing of degradable implants that regenerate body functions and improve quality of life. Our products, made from Artelon®, meet unmet clinical needs and are marketed in a growing number of therapy areas. Artimplant produces implants for treatment of osteoarthritis in hands and feet, for shoulder and other soft tissue injuries as well as oral applications. Artimplant is a public company listed on the OMX Nordic Exchange Stockholm in the Small Cap segment and in the healthcare sector. Forward-looking statements This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks detailed from time to time in the Company's filings.
Artimplant presents the three months interim report 2008 at the AGM on May 6, 05:00 PM (GMT+1)
| Source: Artimplant AB